Thymalin
Thymalin (Thymus Extract Peptide)
Thymalin is a polypeptide complex derived from bovine thymus gland tissue, containing a mixture of short-chain peptides including thymopoietin fragments and other thymic factors. It is primarily used in Eastern European clinical practice and research for immune modulation, age-related immune decline, and as a cytoprotective agent in oncology support and chronic disease states. It has been extensively studied in Russian and Ukrainian clinical trials for its ability to restore immune function in immunocompromised individuals.
Mechanism of Action
Thymalin exerts its effects by interacting with thymic peptide receptors on T-lymphocyte precursors, promoting their differentiation and maturation into functional T-cells within the thymus and peripheral tissues. It modulates cytokine production—particularly IL-1, IL-2, and interferon-gamma—and restores the CD4+/CD8+ T-cell ratio in immunodepleted states. Additionally, it exhibits antioxidant properties and influences neuroendocrine signaling through interactions with the hypothalamic-pituitary axis, contributing to its reported geroprotective effects.
Evidence by Health Goal(17 goals)
Dosing Protocols
Morning, intramuscular or subcutaneous injection
Cycle: 10-day course, repeated 2-4 times per year
Traditional clinical protocols from Russian literature use 10-day courses of 5-10mg/day IM. Some longevity-focused protocols use 20mg/day subcutaneously for 10 days, 2-4 cycles annually. Reconstitute lyophilized powder with sterile bacteriostatic water to 1-2mg/mL.
Safety & Side Effects
Thymalin has a generally favorable safety profile based on decades of Eastern European clinical use, with no serious adverse events consistently reported in published literature at recommended doses. However, it should be used with caution in individuals with autoimmune conditions, organ transplant recipients on immunosuppression, and those with active hematologic malignancies, as immune stimulation could be counterproductive; regulatory status varies significantly by country and it is not approved by the FDA or EMA.
Possible Side Effects
- !Injection site redness, swelling, or mild pain (most common with IM administration)
- !Transient low-grade fever or flu-like symptoms during initial immune activation
- !Fatigue or malaise in the first 1-3 days of a course
- !Mild allergic reactions including skin rash or urticaria in sensitive individuals
- !Temporary lymph node tenderness due to immune cell proliferation
- !Headache reported in a minority of users during initial dosing
Interactions
- -May antagonize immunosuppressive drugs (cyclosporine, tacrolimus, corticosteroids) by stimulating T-cell activity — avoid concurrent use in transplant patients
- -Potential additive immunostimulatory effects with other thymic peptides (Thymosin Alpha-1, Thymogen) — monitor for immune overstimulation
- -May enhance efficacy of vaccines when co-administered — some protocols intentionally leverage this for adjuvant-like effect
- -Use caution with chemotherapy agents: may partially offset myelosuppression but timing relative to cytotoxic therapy requires medical supervision
- -May interact with interferon-based therapies by additively upregulating Th1 cytokine signaling
Cost & Where to Buy
Thymalin is available as lyophilized powder from Russian pharmaceutical sources (e.g., Peptide Bioregulator brands) and research peptide vendors. Cost per 10-day course ranges from $20-60 depending on source and purity. Two courses per month (if used aggressively) would approach the high estimate; standard two-to-four courses annually brings effective monthly amortized cost to the lower range.
Search on Amazon